The Future Begins Here

We know how hard the IVF journey is for prospective parents — ​we’re doing all we can to make it better. LifeView Embryo ​Screening and Tests reduce the risk of miscarriage and genetic ​disease, increasing  the success of fertility treatments.

Quick Start Guide

  • What services or tests do you offer?

    LifeView™  provides ​advanced genetic screening for ​the IVF embryo. Our preimplantation genetic tests include a full suite of tests including PGT-A, PGT-A+, PGT-M, PGT-SR, M2, and The Embryo Health Score Test. 

  • Are your tests covered by insurance?

    Increasing access is very important to us, that's why we work with several fertility benefit providers such as Gaia, Maven, Win Fertility, and Progyny. We also work with financing companies CapexMD and PatientFi. 

    At this time, our tests are not typically covered by insurance. However, we understand the importance of affordability and transparency and are happy to provide documentation to support any reimbursement requests you choose to submit to your insurer. 

  • Can I speak to a genetic counselor?

    We strongly believe in informed decision making, and because of that, we have in-house genetic counselors available to answer your questions and to help guide you. If you order the Embryo Health Score Test, genetic counseling is required as part of our process. 

LifeView PGT powered by Genomic Prediction is ​proven to provide:

The LifeView Testing platform offers patients and their clinicians 

  • Improved accuracy
  • More available embryos for transfer
  • Lower miscarriage rates
  • Higher pregnancy rates

Unlike any other service in the world, LifeView ​patients also have access to Embryo Health Scores, ​which have been proven to reduce the risk of ​common diseases such as diabetes, cancer, and heart ​disease in your embryo. 

Fertility Benefit Partners

Preimplantation Genetic Testing (PGT), helps identify ​chromosomal abnormalities and genetic disorders in embryos ​before transfer, allowing you to select the healthiest ​embryo and increase the chances of a successful ​pregnancy.

Download our flyers to learn more about each test.

PGT options

test symbol

PGT-A

PGT-A screens embryos for aneuploidy so that you and your care team can select an embryo with the correct number of chromosomes (euploid) for transfer, increasing your chances of success and a healthy child.

test symbol

PGT-A+

PGT-A+ is done in conjunction with PGT-A and indicates if the abnormality originated from the egg, sperm, or embryo. PGT-A+ requires saliva samples from the patient, partner, and/or gamete donor in addition to embryo samples. PGT-A+ also acts as a quality assurance – confirming the embryos were created from the correct genetic sources.


test symbol

PGT-M

Monogenic disorders are inherited conditions caused by genetic variants in a single gene. PGT-M is designed for individuals who have a higher chance of passing on these types of conditions to their children.


test symbol

Embryo Health Score® Test

The LifeView Embryo Health Score test evaluates genetic variants to assess the risk of polygenic conditions like diabetes, cancer, schizophrenia, and heart disease in your future child. It also helps you and your clinician compare disease risks among embryos to decide which one to prioritize for transfer.

test symbol

PGT-SR

Individuals who are carriers of balanced chromosome rearrangements have a higher chance of creating embryos with extra or missing genetic material. This can lead to fertility problems, pregnancy loss and health issues in an ongoing pregnancy. PGT-SR is designed to select embryos without such chromosome rearrangements for transfer.

test symbol

M2

Biological parents are screened for a gene associated with increased miscarriage risk. Testing for the M2 haplotype is simple and only requires a saliva sample from the biological parents. If the M2 haplotype is present in any of the biological parents it is possible to screen the embryos for the genetic variant.